PharmaTher Announces FDA Approval of Investigational New Drug (IND) Application for Ketamine to Treat ALS Jan 12, 2022
PharmaTher Enters Into Process Development Agreement With LTS LOHMANN for Ketamine Microneedle Patch Dec 20, 2021
PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent… Nov 30, 2021
PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus Nov 24, 2021
PharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products Oct 19, 2021
